Health Professionals

Immune networks in tumors found to prime responses to personalized immunotherapy

Through an analysis of tumor samples collected over time from patients with advanced melanoma, a Ludwig Cancer Research study has identified a set of preexisting conditions in tumors that predict whether such patients are likely to respond to a personalized immunotherapy known as adoptive T-cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL)

Read More
MRV News
Melanoma News
Archive
Menu